Reuters logo
BRIEF-Alliqua Biomedical posts Q2 adj. $0.09/shr from continuing operations
August 10, 2017 / 11:19 AM / 4 months ago

BRIEF-Alliqua Biomedical posts Q2 adj. $0.09/shr from continuing operations

Aug 10 (Reuters) - Alliqua Biomedical Inc

* Alliqua Biomedical Inc reports second quarter of fiscal year 2017 financial results

* Q2 non-GAAP loss per share $0.09 from continuing operations

* Q2 GAAP loss per share $0.09

* Q2 revenue rose 24 percent to $5.5 million

* Sees FY 2017 revenue up about 12 to 17 percent

* Sees FY 2017 revenue $20.4 million to $21.3 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below